Preventing Pancreatic Cancer: Screening Options & Lifestyle Changes

Last updated and reviewed on June 24, 2026.

Prevention and early detection are two of the most important things in pancreatic cancer research today. Because pancreatic cancer is so often diagnosed at a late stage, researchers and physicians are working hard to identify who is most at risk, develop tools to find it earlier, and understand what changes in behavior or medical management might reduce the chance of developing it in the first place. The picture right now is a mix of important but limited progress: there are meaningful steps people can take, but there is no reliable screening test for the general population yet.

What Is Pancreatic Cancer Screening?

Screening means testing for cancer in people who do not have any symptoms. The goal is to find cancer before it grows large or spreads, when treatment is most likely to be effective.

Right now, there is no recommended routine screening test for pancreatic cancer in the general population. The reason is straightforward: pancreatic cancer is relatively uncommon compared to cancers like breast, colon, or lung cancer, and no available screening test has been shown to reliably find early pancreatic cancers in a way that saves lives across an entire population without causing too many false alarms or unnecessary procedures. A false positive on a pancreatic cancer screening test could lead to invasive procedures with real risks, so any screening tool needs to be both sensitive (good at finding cancer) and specific (not wrongly flagging people who do not have cancer).

However, for people who are at significantly elevated risk because of a known hereditary syndrome or strong family history, structured surveillance programs are available at major medical centers. These programs have been shown to find early-stage pancreatic cancers and precancerous lesions in high-risk individuals, which is a meaningful advance.

Types of Pancreatic Cancer Screening Tests

For high-risk individuals enrolled in surveillance programs, the main tools are imaging tests that provide a detailed look at the pancreas.

• Endoscopic Ultrasound (EUS): Endoscopic ultrasound is considered one of the most sensitive tools for examining the pancreas. During this procedure, a thin, flexible tube with a small ultrasound probe at its tip is passed through the mouth, down the esophagus and stomach, and positioned near the pancreas. Because the probe is right next to the pancreas (rather than outside the body), it can detect very small changes, cysts, and early tumors that CT or standard ultrasound might miss. EUS can also be used to perform a biopsy of a suspicious area. It requires sedation and is performed by a specialist called a gastroenterologist.
• MRI with MRCP (Magnetic Resonance Cholangiopancreatography): MRI is an imaging test that uses magnetic fields and radio waves, not radiation, to create detailed images of the pancreas and surrounding structures. MRCP is a special type of MRI that specifically images the pancreatic duct and bile duct. Together, MRI/MRCP can detect cysts, duct abnormalities, and masses in the pancreas. It is used alongside or alternated with EUS in high-risk surveillance programs.
• CT Scan (Computed Tomography): CT scans are commonly used when pancreatic cancer is suspected based on symptoms, and they provide a clear, detailed cross-sectional view of the pancreas and surrounding organs. However, CT scan involves radiation, and for routine surveillance in young people who need repeated imaging over decades, MRI and EUS are generally preferred.
• CA 19-9 Blood Test: CA 19-9 is a protein that can be detected in the blood and is elevated in many people with pancreatic cancer. However, it is not a reliable standalone screening tool because it can be elevated in benign conditions (like pancreatitis or bile duct obstruction) and is normal in some people who have cancer, including in people with a specific blood type (Lewis negative) who cannot produce CA 19-9 at all. CA 19-9 is most useful for monitoring response to treatment or watching for recurrence after surgery, not for initial screening.
• Emerging Tests: Researchers are actively developing and studying new approaches for earlier pancreatic cancer detection, including blood-based liquid biopsies that look for fragments of tumor DNA or other cancer markers in the blood, urine tests, and artificial intelligence tools that can identify subtle early changes in existing imaging. These approaches are not yet part of standard clinical care but represent one of the most active areas of research in the field.

When Should You Start Screening for Pancreatic Cancer?

For most people, there is currently no recommendation to screen for pancreatic cancer. Screening is primarily recommended for people who are at significantly elevated risk. Major medical organizations, including the American Society for Gastrointestinal Endoscopy and the International Cancer of the Pancreas Screening (CAPS) Consortium, generally recommend that high-risk individuals begin surveillance between ages 40 and 50, or 10 years younger than the youngest affected relative in the family, whichever comes first.

Who is considered high risk? The CAPS guidelines generally recommend surveillance for people with at least one of the following:

1. Have a mutation in a gene known to be associated with elevated pancreatic cancer risk, such as BRCA1, BRCA2, PALB2, ATM, CDKN2A, STK11, MLH1, MSH2, MSH6, or PRSS1.
2. A family history of pancreatic cancer in at least one first-degree relative (parent, sibling, or child) when combined with one of the above gene mutations or with a family in which two or more relatives have had pancreatic cancer.
3. Having hereditary pancreatitis.

If you think you might be at elevated risk, ask your doctor about a referral to a genetic counselor and to a medical center with a formal familial pancreatic cancer surveillance program.

Which Screening Tests Should I Choose?

If you are enrolled in a surveillance program, your doctor will guide you on the best approach. Currently, the combination of EUS and MRI/MRCP alternated every six to twelve months is the most commonly used surveillance strategy for high-risk individuals. EUS tends to be better at detecting small solid masses, while MRI/MRCP is better at characterizing cysts and duct changes. Using both together over time provides the most comprehensive picture.

CT scan is generally reserved for situations where there is a specific concern based on EUS or MRI findings, rather than for routine annual surveillance, because of the cumulative radiation exposure involved in repeated scanning over many years.

Reducing Your Risk of Pancreatic Cancer Through Lifestyle Changes

While there is no guaranteed way to prevent pancreatic cancer, several lifestyle changes can meaningfully reduce your risk and improve your overall health:

• Quit smoking or never start: This is the most impactful single step for reducing pancreatic cancer risk. Smokers have roughly twice the risk of pancreatic cancer compared to non-smokers. The risk decreases after quitting and continues to fall over time. Your doctor can connect you with cessation resources, including counseling, nicotine replacement therapy, and prescription medications.
• Reach and maintain a healthy body weight: Obesity increases pancreatic cancer risk. Eating a balanced diet and staying physically active are the foundations of healthy weight management. Aim for at least 150 minutes of moderate physical activity per week. Even modest weight loss has meaningful health benefits.
• Limit alcohol: Heavy alcohol use is a major cause of chronic pancreatitis, which in turn raises pancreatic cancer risk. The American Cancer Society recommends no more than one drink per day for women and two for men, but less is better when it comes to cancer risk.
• Manage diabetes carefully: Type 2 diabetes is associated with a higher pancreatic cancer risk. Keeping blood sugar well-controlled and, if possible, preventing progression from prediabetes to diabetes through lifestyle changes reduces this risk.
• Eat a plant-forward diet: A diet rich in fruits, vegetables, whole grains, and legumes and lower in red meat and processed foods supports overall health and may modestly reduce pancreatic cancer risk.
• Avoid workplace chemical exposure: If you work with pesticides, solvents, or other industrial chemicals, follow safety protocols and use appropriate protective equipment.
• Know your family history: This is not a lifestyle change, but it is one of the most important things you can do. If pancreatic cancer has occurred in multiple close relatives, or if you have been told you carry a gene mutation linked to pancreatic cancer, discuss surveillance with your doctor.

Sources

1. American Cancer Society. Can Pancreatic Cancer Be Prevented? https://www.cancer.org/cancer/types/pancreatic-cancer/causes-risks-prevention/prevention.html
2. Canto MI, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62(3):339-347. https://pubmed.ncbi.nlm.nih.gov/23135763/
3. Pancreatic Cancer Action Network. Screening and Early Detection. https://www.pancan.org/facing-pancreatic-cancer/learn/about-pancreatic-cancer/early-detection/
4. Goggins M, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020;69(1):7-17. https://pubmed.ncbi.nlm.nih.gov/31672839/
5. American Cancer Society. ACS Guidelines for Diet and Physical Activity. https://www.cancer.org/cancer/risk-prevention/diet-physical-activity/acs-guidelines-nutrition-physical-activity-cancer-prevention.html